LLY Earnings Date & History
Eli Lilly and Co (NEW YORK STOCK EXCHANGE, INC.) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 6:23 PM ET
Eli Lilly and Co
Pharmaceuticals
- Next earnings date
- Thursday, October 29, 2026
- Reporting session
- Time TBD
- EPS estimate
- $9.81
- Revenue estimate
- $22.38B
LLY earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Wednesday, August 5, 2026 | Q2 2026 | $6.07 | $8.38 | +38.1% | $22.97B |
| Thursday, April 30, 2026 | Q1 2026 | $6.73 | $8.55 | +27.0% | $19.80B |
| Wednesday, February 4, 2026 | Q4 2025 | $6.74 | $7.54 | +11.9% | $19.29B |
| Thursday, October 30, 2025 | Q3 2025 | $5.75 | $7.02 | +22.0% | $17.60B |
| Thursday, August 7, 2025 | Q2 2025 | $5.51 | $6.31 | +14.5% | $15.56B |
What the market is watching in LLY's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next LLY earnings date?
- Eli Lilly and Co is scheduled to report on Thursday, October 29, 2026 (Time TBD). Dates can change until the company confirms them.
- Does LLY report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for LLY?
- Consensus EPS for the upcoming quarter is $9.81, on revenue of $22.38B.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
LLY earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.